The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
CYPTAM-BRUT 2: A prospective multicenter observational study in the neoadjuvant and metastatic setting investigating tamoxifen response between women with a favorable versus unfavorable endoxifen profile.
A. Dieudonné
No relevant relationships to disclose
H. Wildiers
No relevant relationships to disclose
D. Lambrechts
No relevant relationships to disclose
H. Guchelaar
No relevant relationships to disclose
V. O. Dezentje
No relevant relationships to disclose
M. Joerger
No relevant relationships to disclose
K. Zaman
No relevant relationships to disclose
I. B. Vergote
No relevant relationships to disclose
P. Neven
No relevant relationships to disclose